Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Daniela Fangmann"'
Autor:
Femke-Anouska Heinsen, Daniela Fangmann, Nike Müller, Dominik M. Schulte, Malte C. Rühlemann, Kathrin Türk, Ute Settgast, Wolfgang Lieb, John F. Baines, Stefan Schreiber, Andre Franke, Matthias Laudes
Publikováno v:
Obesity Facts, Vol 9, Iss 6, Pp 379-391 (2016)
Objective: In the present study, we examined the effect of a very low-calorie diet(VLCD)-based obesity program on human gut microbiome diversity and metabolism during weight loss and weight maintenance. Methods: Obese subjects underwent 3 months of V
Externí odkaz:
https://doaj.org/article/d6e5dcb3a3ea4d0a92f75c66dc1e4103
Autor:
Ute Settgast, Stefan Schreiber, Karin Schwarz, Matthias Laudes, Jana Köpke, Corinna Geisler, Anika Tiede, Karina Altmann, Dominik M. Schulte, Peter Ch Lorenzen, Ingrid Clawin-Rädecker, K Türk, Daniela Fangmann, Kristina Schlicht, Katharina Hartmann
Publikováno v:
Clinical Nutrition. 40:600-607
Summary Background FGF-21 is described as a powerful metabolic regulator with beneficial effects including glucose-lowering and improvement of insulin sensitivity without hypoglycaemia. On the other hand, FGF-21 is activated when muscle and other tis
Publikováno v:
Der Diabetologe. 15:318-324
In den vergangenen Jahren wurde in einer Vielzahl von Studien gezeigt, dass Veranderungen des Darmmikrobioms mit Adipositas und Typ-2-Diabetes sowie der nichtalkoholischen Fettlebererkrankung (NAFLD) assoziiert sind. Im Rahmen des vorliegenden Beitra
Autor:
Matthias Laudes, Esther Appel, Eva-Maria Theismann, Stefan Schreiber, Julia K. Keppler, Stanislav N. Gorb, Daniela Fangmann, Karin Schwarz, Jörg-Rainer Knipp, Georg H. Waetzig
Publikováno v:
International Journal of Pharmaceutics, 564, 472-484
International Journal of Pharmaceutics 564 (2019)
International Journal of Pharmaceutics 564 (2019)
Formulations for the controlled release of substances in the human terminal ileum and colon are essential to target the gut microbiome and its interactions with the intestinal mucosa. In contrast to pharmaceutical enteric coatings, reliable food-grad
Autor:
K Türk, Ateequr Rehman, Matthias Laudes, Karin Schwarz, Georg H. Waetzig, Dominik M. Schulte, Dirk Seegert, Julia K. Keppler, Eva-Maria Theismann, Femke-Anouska Heinsen, Isabelle Relling, Philip Rosenstiel, Stanislav N. Gorb, Esther Appel, Andre Franke, Jörg-Rainer Knipp, Stefan Schreiber, Lennart Lenk, Daniela Fangmann, Sandra Freitag-Wolf, Charles Brenner, Katharina Hartmann
Publikováno v:
Diabetes Care 41 (2018) 3
Diabetes Care, 41(3), 398-405
Diabetes Care, 41(3), 398-405
OBJECTIVE Gut microbiota represent a potential novel target for future prediabetes and type 2 diabetes therapies. In that respect, niacin has been shown to beneficially affect the host-microbiome interaction in rodent models. RESEARCH DESIGN AND METH
Autor:
P Rosenstiel, I Relling, K Türk, Matthias Laudes, Karin Schwarz, G. Wätzig, Daniela Fangmann, Katharina Hartmann, J Knipp, EM Theismann, Dirk Seegert, A Rehmann, Stefan Schreiber, Sandra Freitag-Wolf, J Keppler, Dominik M. Schulte
Publikováno v:
Diabetologie und Stoffwechsel. 12:S1-S84
Autor:
F Brix, Julia Jensen-Kroll, Karin Schwarz, Matthias Laudes, Katharina Hartmann, Stefan Schreiber, Daniela Fangmann, T Demetrowitsch, Juliane Brandes, K Türk
Publikováno v:
Diabetes – Nicht nur eine Typ-Frage – www.diabeteskongress.de.
Autor:
C Knappe, Ute Settgast, Matthias Laudes, A Dempfle, Katharina Hartmann, Daniela Fangmann, Karin Schwarz, Dominik M. Schulte, T Demetrowitsch, K Türk, B Gruber, Andre Franke, Stefan Schreiber
Publikováno v:
Diabetes – Nicht nur eine Typ-Frage – www.diabeteskongress.de.
Autor:
Dominik M. Schulte, Matthias Laudes, Daniela Fangmann, C Knappe, K Türk, Stefan Schreiber, Katharina Hartmann, Ute Settgast, S Brodesser, A Tiede, A Zietsch
Publikováno v:
Diabetes – Nicht nur eine Typ-Frage – www.diabeteskongress.de.
Autor:
Daniela Fangmann, Ute Settgast, John F. Baines, K Türk, Matthias Laudes, Malte C. Rühlemann, N Müller, Femke-Anouska Heinsen, Wolfgang Lieb, Andre Franke, Stefan Schreiber, Dominik M. Schulte
Publikováno v:
Obesity Facts, Vol 9, Iss 6, Pp 379-391 (2016)
Obesity Facts
Obesity Facts
Objective: In the present study, we examined the effect of a very low-calorie diet(VLCD)-based obesity program on human gut microbiome diversity and metabolism during weight loss and weight maintenance. Methods: Obese subjects underwent 3 months of V